Remove 2028 Remove Documentation Remove Hospitals
article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

According to Novartis, Kesimpta is the first targeted B cell therapy for RMS that can be self-administered at home once a month using an autoinjector, avoiding the need for patients to travel to hospital during the pandemic, and easing the pressure on clinicians. billion by 2028. billion in sales in 2028.

Hospitals 111
article thumbnail

The Inflation Reduction Act: The Impact of Medicare Negotiation of Prescription Drug Prices on Hospitals and Health Systems

Omnicell

Hospitals and health systems have long advocated for lower prescription drug prices. In March, in a statement to the Senate Finance Committee, the American Hospital Association contended that prescription drug price inflation constituted “an urgent need to lower drug prices in Medicare.” ” Sen. John Barrasso (R-Wyo.)

article thumbnail

A history of blood cancer treatment

pharmaphorum

During his time working in the pathology museum at Guy’s Hospital in London, Hodgkin studied several preserved specimens of human organs affected by disease. The first well-documented case of multiple myeloma was reported in 1844 by renowned British surgeon Samuel Solly. 1844 – First reported case of multiple myeloma.